North America Bloodstream Infection Testing Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents & Consumables), By Sample Type, By Technology, By End-user, By Region, And Segment Forecasts, 2023 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation and Scope
                        1.1.1. Segment Definitions
                            1.1.1.1. Sample Type segment
                            1.1.1.2. Product segment
                            1.1.1.3. Technology segment
                            1.1.1.4. End-user segment
                    1.2. Regional Scope
                    1.3. Estimates and Forecast Timeline
                    1.4. Objectives
                        1.4.1. Objective - 1
                        1.4.2. Objective - 2
                        1.4.3. Objective - 3
                    1.5. Research Methodology
                    1.6. Information Procurement
                        1.6.1. Purchased Database
                        1.6.2. GVR’s Internal Database
                        1.6.3. Secondary Sources
                        1.6.4. Primary research
                    1.7. Information or Data Analysis
                        1.7.1. Data Analysis Models
                    1.8. Market Formulation & Validation
                    1.9. Model Details
                        1.9.1. Commodity Flow Analysis
                    1.10. List of Secondary Sources
                    1.11. List of Abbreviations
Chapter 2. Executive Summary
                    2.1. Market Snapshot
                    2.2. Product and Sample Type Snapshot
                    2.3. Technology and End-user Snapshot
                    2.4. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent Market Outlook
                        3.1.2. Related/Ancillary Market Outlook
                    3.2. Market Dynamics
                        3.2.1. Market Driver Analysis
                            3.2.1.1. Increasing prevalence of infectious diseases
                            3.2.1.2. Technological Advancements in Bloodstream infection testing
                            3.2.1.3. Growing Initiatives for blood donations campaign
                        3.2.2. Market Restraint Analysis
                            3.2.2.1. High Diagnosis Cost and Lower Investments in Underdeveloped Countries
                    3.3. Industry Analysis Tools
                        3.3.1. Porter’s Five Forces Analysis
                        3.3.2. PESTEL Analysis
                        3.3.3. COVID-19 Impact Analysis
Chapter 4. North America Bloodstream Infection Testing Market: Product Business Analysis
                    4.1. North America Bloodstream Infection Testing Market: Product Movement Analysis
                    4.2. Instruments
                        4.2.1. Instruments Market, 2018 - 2030 (USD Million)
                    4.3. Reagents and Consumables
                        4.3.1. Reagents and Consumables Market, 2018 - 2030 (USD Million)
Chapter 5. North America Bloodstream Infection Testing Market: Sample Type Business Analysis
                    5.1. North America Bloodstream Infection Testing Market: Sample Type Movement Analysis
                    5.2. Whole Blood
                        5.2.1. Whole Blood Market, 2018 - 2030 (USD Million)
                    5.3. Blood Culture
                        5.3.1. Blood Culture Market, 2018 - 2030 (USD Million)
Chapter 6. North America Bloodstream Infection Testing Market: Technology Business Analysis
                    6.1. North America Bloodstream Infection Testing Market: Technology Movement Analysis
                    6.2. PCR
                        6.2.1. PCR Market, 2018 - 2030 (USD Million)
                    6.3. Mass Spectroscopy
                        6.3.1. Mass Spectroscopy Market, 2018 - 2030 (USD Million)
                    6.4. In Situ Hybridization
                        6.4.1. In Situ Hybridization Market, 2018 - 2030 (USD Million)
                    6.5. Others
                        6.5.1. Others Market, 2018 - 2030 (USD Million)
Chapter 7. North America Bloodstream Infection Testing Market: End-User Business Analysis
                    7.1. North America Bloodstream Infection Testing Market: End-User Movement Analysis
                    7.2. Hospitals & Diagnostic Centers
                        7.2.1. Hospitals & Diagnostics Centers Market, 2018 - 2030 (USD Million)
                    7.3. Custom Laboratory Service Providers
                        7.3.1. Custom Laboratory Service Providers Market, 2018 - 2030 (USD Million)
                    7.4. Academic & Research Institutes
                        7.4.1. Academic & Research Institutes Market, 2018 - 2030 (USD Million)
                    7.5. Others
                        7.5.1. Others Market, 2018 - 2030 (USD Million)
Chapter 8. North America Bloodstream Infection Testing Market: Regional Business Analysis
                    8.1. North America
                        8.1.1. SWOT Analysis
                        8.1.2. North America Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
                        8.1.3. U.S.
                            8.1.3.1. Key Country Dynamics
                            8.1.3.2. Target Disease Prevalence
                            8.1.3.3. Competitive Scenario
                            8.1.3.4. Regulatory Framework
                            8.1.3.5. U.S. Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
                        8.1.4. Canada
                            8.1.4.1. Key Country Dynamics
                            8.1.4.2. Target Disease Prevalence
                            8.1.4.3. Competitive Scenario
                            8.1.4.4. Regulatory Framework
                            8.1.4.5. Canada Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
Chapter 9. North America Bloodstream Infection Testing Market: Competitive Landscape
                    9.1. Participant Categorization
                        9.1.1. bioMérieux SA
                            9.1.1.1. Overview
                            9.1.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            9.1.1.3. Product Benchmarking
                            9.1.1.4. Strategic Initiatives
                        9.1.2. BD
                            9.1.2.1. Overview
                            9.1.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            9.1.2.3. Product Benchmarking
                            9.1.2.4. Strategic Initiatives
                        9.1.3. Cepheid
                            9.1.3.1. Overview
                            9.1.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            9.1.3.3. Product Benchmarking
                            9.1.3.4. Strategic Initiatives
                        9.1.4. Seegene Inc.
                            9.1.4.1. Overview
                            9.1.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            9.1.4.3. Product Benchmarking
                            9.1.4.4. Strategic Initiatives
                        9.1.5. Abbott
                            9.1.5.1. Overview
                            9.1.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            9.1.5.3. Product Benchmarking
                            9.1.5.4. Strategic Initiatives
                        9.1.6. F. Hoffmann-La Roche Ltd
                            9.1.6.1. Overview
                            9.1.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            9.1.6.3. Product Benchmarking
                            9.1.6.4. Strategic Initiatives
                        9.1.7. Siemens Healthcare Limited
                            9.1.7.1. Overview
                            9.1.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            9.1.7.3. Product Benchmarking
                            9.1.7.4. Strategic Initiatives
                        9.1.8. Luminex Corporation
                            9.1.8.1. Overview
                            9.1.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            9.1.8.3. Product Benchmarking
                            9.1.8.4. Strategic Initiatives
                        9.1.9. Bruker
                            9.1.9.1. Overview
                            9.1.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            9.1.9.3. Product Benchmarking
                            9.1.9.4. Strategic Initiatives
                        9.1.10. Accelerate Diagnostics, Inc.
                            9.1.10.1. Overview
                            9.1.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            9.1.10.3. Product Benchmarking
                            9.1.10.4. Strategic Initiatives
                    9.2. Participant’s Overview
                    9.3. Financial Performance
                    9.4. Product Benchmarking
                    9.5. Company Market Share Analysis, 2022
                    9.6. Strategy Mapping
                        9.6.1. Expansion
                        9.6.2. Acquisition
                        9.6.3. Product/Service Launch
                        9.6.4. Others
Chapter 10. Analyst View

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 North America Bloodstream Infection Testing Market, By Country, 2018 - 2030 (USD Million)
Table 4 North America Bloodstream Infection Testing Market, By Product, 2018 - 2030 (USD Million)
Table 5 North America Bloodstream Infection Testing Market, By Sample Type, 2018 - 2030 (USD Million)
Table 6 North America Bloodstream Infection Testing Market, By Technology, 2018 - 2030 (USD Million)
Table 7 North America Bloodstream Infection Testing market, by End-user, 2018 - 2030 (USD Million)
Table 8 U.S. Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
Table 9 U.S. Bloodstream Infection Testing market, by Sample Type, 2018 - 2030 (USD Million)
Table 10 U.S. Bloodstream Infection Testing Market, By Technology, 2018 - 2030 (USD Million)
Table 11 U.S. Bloodstream Infection Testing market, by End-user, 2018 - 2030 (USD Million)
Table 12 Canada Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
Table 13 Canada Bloodstream Infection Testing market, by Sample Type, 2018 - 2030 (USD Million)
Table 14 Canada Bloodstream Infection Testing Market, By Technology, 2018 - 2030 (USD Million)
Table 15 Canada Bloodstream Infection Testing market, by End-user, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 Market formulation & validation
Fig. 7 Microscope software, market segmentation
Fig. 8 Market snapshot, 2022
Fig. 9 Market Trends & Outlook
Fig. 10 Market driver relevance analysis (current & future impact)
Fig. 11 Market restraint relevance analysis (current & future impact)
Fig. 12 Market challenge relevance analysis (current & future impact)
Fig. 13 SWOT analysis
Fig. 14 Porter’s five forces analysis
Fig. 15 Regional marketplace: key takeaways
Fig. 16 Regional outlook, 2022 & 2030
Fig. 17 North America bloodstream infection testing market: region movement analysis.
Fig. 18 North America bloodstream infection testing market, 2018 - 2030 (USD Million)
Fig. 19 U.S. key country dynamics
Fig. 20 U.S. bloodstream infection testing market, 2018 - 2030 (USD Million)
Fig. 21 Canada key country dynamics
Fig. 22 Canada bloodstream infection testing market, 2018 - 2030 (USD Million)